<code id='2EA9ECD293'></code><style id='2EA9ECD293'></style>
    • <acronym id='2EA9ECD293'></acronym>
      <center id='2EA9ECD293'><center id='2EA9ECD293'><tfoot id='2EA9ECD293'></tfoot></center><abbr id='2EA9ECD293'><dir id='2EA9ECD293'><tfoot id='2EA9ECD293'></tfoot><noframes id='2EA9ECD293'>

    • <optgroup id='2EA9ECD293'><strike id='2EA9ECD293'><sup id='2EA9ECD293'></sup></strike><code id='2EA9ECD293'></code></optgroup>
        1. <b id='2EA9ECD293'><label id='2EA9ECD293'><select id='2EA9ECD293'><dt id='2EA9ECD293'><span id='2EA9ECD293'></span></dt></select></label></b><u id='2EA9ECD293'></u>
          <i id='2EA9ECD293'><strike id='2EA9ECD293'><tt id='2EA9ECD293'><pre id='2EA9ECD293'></pre></tt></strike></i>

          Home / fashion / hotspot

          hotspot


          hotspot

          author:Wikipedia    Page View:53
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In